James Molloy
Stock Analyst at Alliance Global Partners
(0.58)
# 3,846
Out of 4,743 analysts
32
Total ratings
24.24%
Success rate
-36.43%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $2.55 | +233.01% | 1 | Jan 13, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $14.27 | +145.20% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $15 | $2.14 | +600.93% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $7.88 | +153.81% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $14 | $0.43 | +3,155.81% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $6 → $11 | $0.33 | +3,258.78% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.85 | +105.88% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $3.77 | +165.25% | 1 | Jul 17, 2024 | |
| IGC IGC Pharma | Initiates: Buy | $3.5 | $0.35 | +911.27% | 1 | Jul 17, 2024 | |
| CHRO Channel Therapeutics | Initiates: Buy | n/a | $2.79 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $0.92 | +1,424.22% | 2 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.41 | +2,027.66% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.13 | +563.72% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.25 | +280.95% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.99 | +708.98% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $3.13 | +123.64% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.22 | +6,457.38% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.89 | +746.56% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.83 | +1,590.62% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.96 | +1,466.58% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $0.41 | +58,237.38% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $2.30 | +6,421.74% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $0.33 | +18,668.77% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $3.00 | +733.33% | 1 | Oct 4, 2021 |
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $2.55
Upside: +233.01%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $14.27
Upside: +145.20%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $2.14
Upside: +600.93%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $7.88
Upside: +153.81%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $14
Current: $0.43
Upside: +3,155.81%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $6 → $11
Current: $0.33
Upside: +3,258.78%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.85
Upside: +105.88%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $3.77
Upside: +165.25%
IGC Pharma
Jul 17, 2024
Initiates: Buy
Price Target: $3.5
Current: $0.35
Upside: +911.27%
Channel Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $2.79
Upside: -
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $0.92
Upside: +1,424.22%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.41
Upside: +2,027.66%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.13
Upside: +563.72%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $5.25
Upside: +280.95%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $0.99
Upside: +708.98%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $3.13
Upside: +123.64%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $1.22
Upside: +6,457.38%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $1.89
Upside: +746.56%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $0.83
Upside: +1,590.62%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $0.96
Upside: +1,466.58%
Sep 7, 2022
Initiates: Buy
Price Target: $240
Current: $0.41
Upside: +58,237.38%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $2.30
Upside: +6,421.74%
Jun 1, 2022
Initiates: Buy
Price Target: $63
Current: $0.33
Upside: +18,668.77%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $3.00
Upside: +733.33%